BioSpace News Archive

Analysis shows participants who stayed in the program at least 6 months reduced their diabetes drug costs by 18%.

Tetra Bio-Pharma Inc. announces the launch of its new wholly owned subsidiary ‘Tetra Bio-Pharma Australia Pty Ltd’ .

2seventy bio to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference.

Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus resources on Movement Disorders and Epilepsy franchises extends cash runway into 2024.

Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings.

Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450) for their new innovative and quantitative test system.

EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that three oral presentations will be delivered on its HIFU developments at the 21st Annual International Symposium on Therapeutic Ultrasound (ISTU), which is being held June 7-10, in Toronto and virtually.

Piezo Motion, a Brain Scientific company, announces the release of rotary motors for devices or applications requiring rapid response times, high-torque, micro-radian resolution and almost zero backlash.

Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation, announced today that Chief Executive Officer Diem Nguyen, Ph.D., MBA, will participate in two panels at the BIO International Convention.

AltruBio Inc. announced that president and chief executive officer Judy Chou, Ph.D., will present an in-person corporate overview at the 2022 BIO International Convention taking place June 13-16, 2022 in San Diego, Calif.